P86 trading today higher at 0.11, an increase of 0% from yesterday's close, completing a monthly increase of 5.7692% or 0.01. Over the past 12 months, P86 stock lost -34.1317%.
P86 is not paying dividends to its shareholders.
The last earnings report, released on Feb 26, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Paradigm Biopharmaceuticals Ltd. has completed 2 stock splits, with the recent split occurring on Nov 01, 2023.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on ASX (AUD).